Literature DB >> 28930665

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Yu Zhu, John M Herndon, Dorothy K Sojka, Ki-Wook Kim, Brett L Knolhoff, Chong Zuo, Darren R Cullinan, Jingqin Luo, Audrey R Bearden, Kory J Lavine, Wayne M Yokoyama, William G Hawkins, Ryan C Fields, Gwendalyn J Randolph, David G DeNardo.   

Abstract

Entities:  

Year:  2017        PMID： 28930665      PMCID： PMC5664180          DOI： 10.1016/j.immuni.2017.08.018

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


× No keyword cloud information.
  63 in total

Review 1.  Macrophages: The Road Less Traveled, Changing Anticancer Therapy.

Authors:  Jennifer L Guerriero
Journal:  Trends Mol Med       Date:  2018-04-11       Impact factor: 11.951

2.  Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma.

Authors:  Emilien Loeuillard; Jingchun Yang; EeeLN Buckarma; Juan Wang; Yuanhang Liu; Caitlin Conboy; Kevin D Pavelko; Ying Li; Daniel O'Brien; Chen Wang; Rondell P Graham; Rory L Smoot; Haidong Dong; Sumera Ilyas
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 3.  Diversity, Mechanisms, and Significance of Macrophage Plasticity.

Authors:  Massimo Locati; Graziella Curtale; Alberto Mantovani
Journal:  Annu Rev Pathol       Date:  2019-09-17       Impact factor: 23.472

4.  An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions.

Authors:  Jialing Zhang; Stephan S Späth; Sherman M Weissman; Samuel G Katz
Journal:  Methods Mol Biol       Date:  2020

Review 5.  Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance.

Authors:  Kristen B Long; Arthur I Collier; Gregory L Beatty
Journal:  Mol Immunol       Date:  2017-12-19       Impact factor: 4.407

6.  B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer.

Authors:  Bhalchandra Mirlekar; Daniel Michaud; Samuel J Lee; Nancy P Kren; Cameron Harris; Kevin Greene; Emily C Goldman; Gaorav P Gupta; Ryan C Fields; William G Hawkins; David G DeNardo; Naim U Rashid; Jen Jen Yeh; Autumn J McRee; Benjamin G Vincent; Dario A A Vignali; Yuliya Pylayeva-Gupta
Journal:  Cancer Immunol Res       Date:  2020-02-05       Impact factor: 11.151

7.  Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma.

Authors:  Ingunn M Stromnes; Adam L Burrack; Ayaka Hulbert; Patrick Bonson; Cheryl Black; J Scott Brockenbrough; Jackson F Raynor; Ellen J Spartz; Robert H Pierce; Philip D Greenberg; Sunil R Hingorani
Journal:  Cancer Immunol Res       Date:  2019-04-26       Impact factor: 11.151

8.  Prolactin Promotes Fibrosis and Pancreatic Cancer Progression.

Authors:  Manuj Tandon; Gina M Coudriet; Angela Criscimanna; Mairobys Socorro; Mouhanned Eliliwi; Aatur D Singhi; Zobeida Cruz-Monserrate; Peter Bailey; Michael T Lotze; Herbert Zeh; Jing Hu; Vincent Goffin; George K Gittes; Andrew V Biankin; Farzad Esni
Journal:  Cancer Res       Date:  2019-08-08       Impact factor: 12.701

Review 9.  The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets.

Authors:  Hirotake Tsukamoto; Yoshihiro Komohara; Hiroyuki Oshiumi
Journal:  Hum Cell       Date:  2021-04-27       Impact factor: 4.174

Review 10.  The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates.

Authors:  Eslam Mohamed; Amir A Al-Khami; Paulo C Rodriguez
Journal:  Cell Mol Immunol       Date:  2018-03-22       Impact factor: 11.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.